This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1995 Feb;16(1):87-116.

doi: 10.1210/edrv-16-1-87.

Osteoporosis in men

E S Orwoll¹, R F Klein

Affiliations

PMID: 7758434
DOI: 10.1210/edrv-16-1-87

Review

Osteoporosis in men

E S Orwoll et al. Endocr Rev. 1995 Feb.

. 1995 Feb;16(1):87-116.

doi: 10.1210/edrv-16-1-87.

Authors

E S Orwoll¹, R F Klein

Affiliation

¹ Bone and Mineral Research Unit, Portland Veterans Administration Medical Center, Oregon, USA.

PMID: 7758434
DOI: 10.1210/edrv-16-1-87

No abstract available

PubMed Disclaimer

Similar articles

Osteoporosis: a focus on treatment.
Shiflett S, Cooke CE. Shiflett S, et al. Md Med J. 1997 Jul;46(6):303-7. Md Med J. 1997. PMID: 9579203 Review. No abstract available.
Role of hormonal changes in the pathogenesis of osteoporosis in men.
Khosla S. Khosla S. Calcif Tissue Int. 2004 Aug;75(2):110-3. doi: 10.1007/s00223-004-0290-y. Epub 2004 Apr 29. Calcif Tissue Int. 2004. PMID: 15129370 Review. No abstract available.
Does bone density predict fractures comparably in men and women?
Melton LJ 3rd, Orwoll ES, Wasnich RD. Melton LJ 3rd, et al. Osteoporos Int. 2001;12(9):707-9. doi: 10.1007/s001980170044. Osteoporos Int. 2001. PMID: 11605734 Review. No abstract available.
Investigation of osteoporosis.
Smith R. Smith R. Clin Endocrinol (Oxf). 1996 Apr;44(4):371-4. doi: 10.1046/j.1365-2265.1996.702520.x. Clin Endocrinol (Oxf). 1996. PMID: 8706302 Review. No abstract available.
Peak bone mass, bone loss and risk of fracture.
Johnston CC Jr, Slemenda CW. Johnston CC Jr, et al. Osteoporos Int. 1994;4 Suppl 1:43-5. doi: 10.1007/BF01623435. Osteoporos Int. 1994. PMID: 8081058 Review.

See all similar articles

Cited by

Management of osteoporosis in the aging male: focus on zoledronic acid.
Piper PK Jr, Gruntmanis U. Piper PK Jr, et al. Clin Interv Aging. 2009;4:289-303. doi: 10.2147/cia.s4295. Epub 2009 Jun 29. Clin Interv Aging. 2009. PMID: 19750231 Free PMC article. Review.
Alendronate for osteoporosis in men with androgen-repleted hypogonadism.
Shimon I, Eshed V, Doolman R, Sela BA, Karasik A, Vered I. Shimon I, et al. Osteoporos Int. 2005 Dec;16(12):1591-6. doi: 10.1007/s00198-005-1879-3. Epub 2005 Mar 15. Osteoporos Int. 2005. PMID: 16362147 Clinical Trial.
Prevalence of Hypogonadism in Low-Risk Prostate Cancer Survivors.
Agrawal L, Arceo-Mendoza RM, Barnosky A, Bresler L, Chiha M, Silva A, Wilczynski C. Agrawal L, et al. Fed Pract. 2016 May;33(Suppl 4):37S-43S. Fed Pract. 2016. PMID: 30766218 Free PMC article.
Relationship of sex steroid hormones with bone mineral density (BMD) in a nationally representative sample of men.
Paller CJ, Shiels MS, Rohrmann S, Basaria S, Rifai N, Nelson W, Platz EA, Dobs A. Paller CJ, et al. Clin Endocrinol (Oxf). 2009 Jan;70(1):26-34. doi: 10.1111/j.1365-2265.2008.03300.x. Epub 2008 May 14. Clin Endocrinol (Oxf). 2009. PMID: 18485120 Free PMC article.
Correlations between serum testosterone, estradiol, and sex hormone-binding globulin and bone mineral density in a diverse sample of men.
Araujo AB, Travison TG, Leder BZ, McKinlay JB. Araujo AB, et al. J Clin Endocrinol Metab. 2008 Jun;93(6):2135-41. doi: 10.1210/jc.2007-1469. Epub 2008 Mar 25. J Clin Endocrinol Metab. 2008. PMID: 18364385 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

R01 AA011317/AA/NIAAA NIH HHS/United States

LinkOut - more resources

Full Text Sources
- Silverchair Information Systems
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information